Public Health Interventions: Evaluating the Economic Evaluations

NICE. Structure of NICE. 2012. Available from: http://www.nice.org.uk/aboutnice/whoweare/structureofnice/structure_of_nice.jsp Accessed on: September, 2013.

NICE. Methods for the development of NICE public health guidance (third edition). 2012. Available from: http://publications.nice.org.uk/PMG4. Accessed on: September, 2013.

Messonnier M. Economics and Public Health at CDC. Morbidity and mortality weekly report 2006. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/su5502a7.htm. Accessed on: September, 2013.

Honeycutt A , Clayton L , Khavjou O , . Guide to analyzing the cost-effectiveness of community public health prevention approaches. Office for the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services. March 2006. Available from: http://aspe.hhs.gov/health/reports/06/cphpa/. Accessed on: September, 2013.

Drummond M , Sculpher M , Torrance G , . Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.

Jennison C , Turnbull B. Group sequential methods with applications to clinical trials. Boca Raton; Chapman and Hall/CRC; 2000.

Hampson L , Jennison C. Group sequential tests for delayed responses. J R Stat Soc Series B 2013;75:3–54.

Berry S , Carlin B , Lee J , Muller P. Bayesian adaptive methods for clinical trials. Boca Raton: Chapman and Hall/CRC; 2011.

Hendricks-Brown C , Ten Have T , Jo B , . Adaptive designs for randomized trials in public health. Ann Rev Public Health 2009;30:1–25.

NICE. Appendix K Examples of evidence tables. Available from: http://publications.nice.org.uk/methods-for-the-development-of-nice-public-health-guidance-third-edition-pmg4/appendix-k-examples-of-evidence-tables. Accessed on: September, 2013.

Forster M , Pertile P. Optimal decision rules for HTA under uncertainty: a wider, dynamic perspective. Health Economics 2012 [Ahead of Print]

Griffin S , Claxton K , Palmer S , Sculpher M. Dangerous omissions: the consequences of ignoring decision uncertainty. Health Economics 2011;20:212–24.

Willan A , Eckermann S. Optimal clinical trial design using value of information methods with imperfect implementation. Health Economics 2010;19:549–61.